🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Medulloblastoma

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site📍 Boadilla del Monte Fundación de investigación HM · Tests: Olaparib; 177Lu-DOTATATE Cognitive Rehabilitation for Survivors of Childhood Medulloblastoma Using Real Time Hemodynamic Neurofeedback NCT07830134NA1 site📍 Memphis St. Jude Children's Research Hospital · Tests: rt fMRI Neurofeedback (DLPFC), rt fMRI Neurofeedback (PAC) Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma NCT05535166Phase 210 sites📍 Palo Alto📍 Orlando📍 Tampa St. Jude Children's Research Hospital · Tests: Surgical resection, Ommaya/VPS, Methotrexate, Cisplatin, Vincristine Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease NCT07346157Phase 1, Phase 23 sites📍 San Francisco📍 Washington D.C.📍 Seattle Sabine Mueller, MD, PhD · Tests: Liothyronine (L-T3), Bevacizumab, Irinotecan, Temozolomide (TMZ) Atovaquone Combined With Radiation in Children With Malignant Brain Tumors NCT06624371Phase 12 sites📍 Atlanta📍 Atlanta Emory University · Tests: Atovaquone, Radiation Therapy Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study NCT07242963n/a2 sites📍 Houston📍 Houston Mohammad H. Abu Arja Focal Radiotherapy Plus Low Dose Craniospinal Irradiation Followed by Adjuvant Chemotherapy in WNT Medulloblastoma. NCT04474964NA1 site📍 Mumbai Tata Memorial Centre · Tests: Low dose Craniospinal Irradiation plus Focal Radiotherapy Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors NCT07584499Phase 11 site📍 Guangzhou Sun Yat-sen University · Tests: Becotatug Vedotin A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss NCT05382338Phase 3111 sites📍 Birmingham📍 Mobile📍 Phoenix Children's Oncology Group · Tests: Audiometric Test, Auditory Brainstem Response, Biospecimen Collection, Cisplatin, Cyclophosphamide NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors NCT07664176Phase 11 site📍 Washington D.C. Children's National Research Institute · Tests: NeuroNavigation-Guided Focused Ultrasound (NgFUS), Lumason, Nivolumab International HIT-MED Registry (I-HIT-MED) NCT02417324n/a57 sites📍 Aachen📍 Augsburg📍 Berlin Universitätsklinikum Hamburg-Eppendorf Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation NCT06942039EARLY Phase 112 sites📍 Calgary📍 Vancouver📍 Winnipeg C17 Council · Tests: Cytarabine IT, hydrocortisone, Cisplatin, Vincristine, Etoposide Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors NCT04185038Phase 11 site📍 Seattle Seattle Children's Hospital · Tests: SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma NCT06959979EARLY Phase 11 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: CDK4/6 Inhibitor (Palbociclib, Ribociclib, Abemaciclib) A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM) NCT04573140Phase 12 sites📍 Washington D.C.📍 Gainesville University of Florida · Tests: Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane protein (LAMP) mRNA loaded DOTAP li… A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies. NCT07017816EARLY Phase 11 site📍 Washington D.C. Children's National Research Institute · Tests: SGT-53, hypofractionated radiotherapy with immunotherapy, Nivolumab DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma NCT04696029Phase 226 sites📍 Little Rock📍 Oakland📍 Sacramento Giselle Sholler · Tests: Difluoromethylornithine Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour NCT05230758Phase 320 sites📍 New Lambton Heights📍 Westmead📍 Adelaide Donald Mabbott · Tests: Metformin hydrochloride (HCl) 500mg tablet, Placebo HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors NCT03911388Phase 13 sites📍 Birmingham📍 St Louis📍 Houston M.D. Anderson Cancer Center · Tests: G207 Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer NCT05106296Phase 11 site📍 Augusta Theodore S. Johnson · Tests: Indoximod, Ibrutinib, Cyclophosphamide, Etoposide, Ibrutinib 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. NCT04081701Phase 41 site📍 New York Weill Medical College of Cornell University · Tests: Ga68-DOTATATE-PET/MRI Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline NCT06779487n/a1 site📍 Mumbai Tata Memorial Centre A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS) NCT07698899Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: 25 mCi 177Lu- DTPA-omburtamab Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT) NCT06193759Phase 11 site📍 Washington D.C. Children's National Research Institute · Tests: Multi-tumor antigen specific cytotoxic T lymphocytes (TSA-T) directed against proteogenomically determined personalized… Digoxin Medulloblastoma Study NCT06701812Phase 217 sites📍 Birmingham📍 Phoenix📍 Little Rock H. Lee Moffitt Cancer Center and Research Institute · Tests: Digoxin Medulloblastoma Online Video-based Exercise Pilot Study NCT06898684NA2 sites📍 München📍 Gothenburg Aron Onerup · Tests: Exercise Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China NCT05672043n/a1 site📍 Beijing Beijing Tiantan Hospital Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors NCT01356290Phase 222 sites📍 Chicago📍 Boston📍 Grand Rapids Medical University of Vienna · Tests: Bevacizumab, Thalidomide, Celecoxib, Fenofibric acid, Etoposide B7-H3.CD28Z.CART in CNS Neoplasms NCT07390539Phase 12 sites📍 Boston📍 Boston Robbie Majzner · Tests: B7-H3.CD28Z.CART, Fludarabine, Cyclophosphamide GD2-CAR T Cells for Pediatric Brain Tumours NCT05298995Phase 11 site📍 Roma Bambino Gesù Hospital and Research Institute · Tests: GD2-CART01 (iC9-GD2-CAR T-cells)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy